Logotype for Outlook Therapeutics Inc

Outlook Therapeutics (OTLK) Proxy Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Outlook Therapeutics Inc

Proxy Filing summary

26 Jan, 2026

Voting matters and shareholder proposals

  • Election of three directors: Faisal G. Sukthian, Yezan Haddadin, and Kurt J. Hilzinger, with board recommending a vote for each.

  • Ratification of KPMG LLP as the independent registered public accounting firm for fiscal year 2026.

  • Non-binding advisory vote on the compensation of named executive officers, with board recommending approval.

  • Additional business may be addressed if properly brought before the meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends all director nominees for election at the annual meeting.

Executive compensation and say-on-pay

  • Shareholders will vote on a non-binding advisory resolution regarding executive officer compensation.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more